Get the Stockscreener App
38.28
0.50%
0.19
After Hours:
38.28
Xenon Pharmaceuticals Inc Stock (XENE) Forecast
The Xenon Pharmaceuticals Inc (XENE) stock price forecast for the next 30 days is generally positive, with an average analyst price target of $71.00, representing a +85.49% increase from the current price of $38.28. The highest analyst price target is $72.41, and the lowest is $69.60.
Disclaimer: The information on this page is not intended to be financial advice. It is for general information only and should not be used to make any investment decisions. Please consult with a professional financial advisor before making any investment decisions.
12-Month XENE Price Target
Average 85.07
(+122.22% Upside)
Is Xenon Pharmaceuticals Inc (XENE) A Buy Now?
Oscillators
| Name | Value | Action |
|---|---|---|
| RSI(14) | 62.83 | Neutral |
| STOCH(9,6) | 89.06 | Sell |
| STOCHRSI(14) | 91.61 | Sell |
| MACD(12,26) | 1.1941 | Buy |
| ADX(14) | 23.07 | Neutral |
| William %R | -9.344 | Sell |
| CCI(14) | 42.30 | Neutral |
Buy: 1
Sell: 3
Neutral: 3
Summary: Neutral
Moving Averages
| Period | Simple | Exponential |
|---|---|---|
| MA10 |
37.56
Buy
|
37.23
Buy
|
| MA20 |
34.65
Buy
|
36.02
Buy
|
| MA50 |
35.16
Buy
|
35.81
Buy
|
| MA100 |
37.45
Buy
|
36.99
Buy
|
| MA200 |
39.29
Sell
|
38.75
Sell
|
Buy: 8
Sell: 2
Neutral: 0
Summary: Buy
According to our latest analysis, XENE could be considered a Strong Buy, with 17 technical analysis indicators signaling 9 Buy signals, 5 signaling Sell signals and 3 Neutral signals. This might be a good time to open fresh positions on XENE, as trading bullish markets is always a lot easier
- RSI (Relative Strength Index): The RSI(14) value of 62.83 indicates that XENE is neither overbought nor oversold. It suggests a neutral sentiment in the short term.
- STOCH (Stochastic Oscillator): The STOCH value of 89.06 indicates that XENE is oversold. This means that XENE price is at or near the highest level over a specified lookback period.
- STOCHRSI (Stochastic Relative Strength Index): The STOCHRSI value of 91.61 indicates that XENE is oversold. This suggests that XENE price is at or near the highest level relative to its recent price history.
- ADX (Average Directional Index): The ADX value of The ADX value of 23.07 suggests that there may be some movement in price, but it lacks strength or conviction.
- CCI (Commodity Channel Index): A CCI(14) value of A CCI(14) value of 42.3 indicates that XENE is not in oversold or overbought territory. It suggests a neutral sentiment in the short term.
Long-term XENE price forecast for 2025, 2030, 2035, 2040, 2045 and 2050
Based on our analysis about Xenon Pharmaceuticals Inc financial reports and earnings history, Xenon Pharmaceuticals Inc (XENE) stock could reach $81.61 by 2030, $437.28 by 2040 and $553.54 by 2050. See the projected annual prices until 2050 of the Xenon Pharmaceuticals Inc stock below:
- Xenon Pharmaceuticals Inc (XENE) is expected to reach an average price of $322.27 in 2035, with a high prediction of $325.84 and a low estimate of $319.96. This indicates an $741.86% rise from the last recorded price of $38.28.
- Xenon Pharmaceuticals Inc (XENE) stock is projected to chart a bullish course in 2040, with an average price target of $436.84, representing an $1,041% surge from its current level. The forecast ranges from a conservative $427.30 to a sky-high $437.28.
- Our analysts predict Xenon Pharmaceuticals Inc (XENE) to jump 1,230% by 2045, soaring from $504.12 to an average price of $509.29, potentially reaching $511.31. While $504.12 is the low estimate, the potential upside is significant.
- Xenon Pharmaceuticals Inc (XENE) stock is expected to climb by 2050, reaching an average of $553.22, a $1,345% jump from its current level. However, a wide range of estimates exists, with high and low targets of $553.54 and $543.45, respectively, highlighting the market's uncertainty.
Xenon Pharmaceuticals Inc Stock (XENE) Year by Year Forecast
Xenon Pharmaceuticals Inc Stock (XENE) Price Forecast for 2025
Xenon Pharmaceuticals Inc Stock (XENE) is expected to reach an average price of $71.28 in 2025, with a high prediction of $81.45 and a low estimate of $61.10. This indicates an +86.20% rise from the last recorded price of $38.28.
| Month | Average | Low | High | Change from today's price |
|---|---|---|---|---|
| June, 2025 | $71.60 | $69.60 | $72.41 | +87.05% |
| July, 2025 | $73.63 | $71.46 | $76.03 | +92.35% |
| August, 2025 | $75.65 | $73.43 | $76.21 | +97.63% |
| September, 2025 | $75.33 | $74.36 | $77.38 | +96.80% |
| October, 2025 | $77.48 | $74.67 | $78.49 | +102.40% |
| November, 2025 | $79.03 | $77.51 | $79.34 | +106.46% |
| December, 2025 | $79.81 | $79.16 | $81.45 | +108.49% |
Xenon Pharmaceuticals Inc Stock (XENE) Price Forecast for 2026
The predicted value for Xenon Pharmaceuticals Inc (XENE) in 2026 is set at an average of $95.23. Estimates vary from a peak of $110.14 to a trough of $80.32, indicating an +148.78% surge from the present price of $38.28.
| Month | Average | Low | High | Change from today's price |
|---|---|---|---|---|
| January, 2026 | $83.19 | $80.32 | $83.32 | +117.32% |
| February, 2026 | $86.73 | $83.44 | $87.29 | +126.57% |
| March, 2026 | $91.25 | $86.77 | $91.73 | +138.38% |
| April, 2026 | $92.26 | $90.03 | $93.94 | +141.01% |
| May, 2026 | $97.93 | $92.51 | $100.53 | +155.83% |
| June, 2026 | $98.34 | $95.85 | $100.08 | +156.90% |
| July, 2026 | $100.19 | $98.08 | $102.67 | +161.72% |
| August, 2026 | $103.15 | $100.22 | $104.81 | +169.46% |
| September, 2026 | $105.29 | $102.31 | $105.65 | +175.04% |
| October, 2026 | $104.88 | $104.12 | $106.39 | +173.97% |
| November, 2026 | $107.73 | $104.55 | $107.90 | +181.42% |
| December, 2026 | $107.48 | $106.78 | $110.14 | +180.76% |
Xenon Pharmaceuticals Inc Stock (XENE) Price Forecast for 2027
For 2027, Stockscan's Analyst expects the average price target for Xenon Pharmaceuticals Inc (XENE) is $131.82, with a high forecast of $155.71 and a low forecast of $107.92. This indicates an +244.35% increase from the last price of $38.28.
| Month | Average | Low | High | Change from today's price |
|---|---|---|---|---|
| January, 2027 | $124.73 | $107.92 | $128.35 | +225.83% |
| February, 2027 | $124.60 | $123.72 | $131.60 | +225.49% |
| March, 2027 | $125.83 | $120.34 | $126.00 | +228.72% |
| April, 2027 | $131.40 | $125.66 | $132.00 | +243.25% |
| May, 2027 | $129.14 | $124.88 | $132.88 | +237.35% |
| June, 2027 | $133.49 | $129.16 | $136.68 | +248.73% |
| July, 2027 | $135.54 | $130.98 | $137.59 | +254.06% |
| August, 2027 | $138.86 | $136.21 | $141.62 | +262.74% |
| September, 2027 | $136.28 | $132.88 | $140.56 | +256.02% |
| October, 2027 | $140.97 | $135.19 | $141.40 | +268.27% |
| November, 2027 | $145.64 | $140.82 | $146.27 | +280.45% |
| December, 2027 | $152.21 | $143.58 | $155.71 | +297.63% |
Xenon Pharmaceuticals Inc Stock (XENE) Price Forecast for 2028
In 2028, Xenon Pharmaceuticals Inc (XENE) is projected to reach an average price of $164.85, with a high projection of $179.34 and a low estimate of $150.36. This indicates an +330.64% rise from the last price of $38.28.
| Month | Average | Low | High | Change from today's price |
|---|---|---|---|---|
| January, 2028 | $155.02 | $150.36 | $156.14 | +304.97% |
| February, 2028 | $153.83 | $152.22 | $156.56 | +301.84% |
| March, 2028 | $156.42 | $152.61 | $157.79 | +308.63% |
| April, 2028 | $156.36 | $152.49 | $158.89 | +308.47% |
| May, 2028 | $161.76 | $157.28 | $163.61 | +322.57% |
| June, 2028 | $161.86 | $159.63 | $164.38 | +322.83% |
| July, 2028 | $166.61 | $161.36 | $167.01 | +335.25% |
| August, 2028 | $163.39 | $163.10 | $169.46 | +326.83% |
| September, 2028 | $166.05 | $162.27 | $167.73 | +333.78% |
| October, 2028 | $175.03 | $164.94 | $175.26 | +357.24% |
| November, 2028 | $173.70 | $172.42 | $176.83 | +353.76% |
| December, 2028 | $174.94 | $173.79 | $179.34 | +357.00% |
Xenon Pharmaceuticals Inc Stock (XENE) Price Forecast for 2029
The 2029 price forecast for Xenon Pharmaceuticals Inc Stock (XENE) is $140.41 on average, with a high prediction of $204.87 and a low estimate of $75.95. This represents an +266.79% increase from the previous price of $38.28.
| Month | Average | Low | High | Change from today's price |
|---|---|---|---|---|
| January, 2029 | $175.49 | $173.40 | $177.76 | +358.43% |
| February, 2029 | $178.32 | $174.48 | $179.55 | +365.82% |
| March, 2029 | $178.83 | $178.30 | $181.50 | +367.16% |
| April, 2029 | $178.81 | $175.89 | $180.64 | +367.11% |
| May, 2029 | $174.63 | $174.35 | $180.04 | +356.18% |
| June, 2029 | $184.30 | $174.21 | $185.21 | +381.45% |
| July, 2029 | $195.26 | $183.67 | $196.20 | +410.08% |
| August, 2029 | $196.55 | $193.71 | $198.50 | +413.44% |
| September, 2029 | $202.49 | $196.67 | $203.62 | +428.96% |
| October, 2029 | $199.15 | $197.39 | $204.87 | +420.26% |
| November, 2029 | $196.74 | $195.87 | $200.04 | +413.94% |
| December, 2029 | $76.00 | $75.95 | $201.71 | +98.54% |
Xenon Pharmaceuticals Inc Stock (XENE) Price Forecast for 2030
Xenon Pharmaceuticals Inc Stock (XENE) is expected to reach an average price of $99.96 in 2030, with a high forecast of $123.29 and a low forecast of $76.62. This signifies an +161.12% surge from the last price of $38.28.
| Month | Average | Low | High | Change from today's price |
|---|---|---|---|---|
| January, 2030 | $80.23 | $76.62 | $81.61 | +109.60% |
| February, 2030 | $84.85 | $81.04 | $85.04 | +121.65% |
| March, 2030 | $87.48 | $85.33 | $88.18 | +128.52% |
| April, 2030 | $90.71 | $87.78 | $90.83 | +136.97% |
| May, 2030 | $94.67 | $91.62 | $94.72 | +147.32% |
| June, 2030 | $97.85 | $95.20 | $98.16 | +155.61% |
| July, 2030 | $102.79 | $98.34 | $103.14 | +168.52% |
| August, 2030 | $110.20 | $103.68 | $110.84 | +187.89% |
| September, 2030 | $116.86 | $110.73 | $117.44 | +205.27% |
| October, 2030 | $121.46 | $116.80 | $122.90 | +217.29% |
| November, 2030 | $119.41 | $118.25 | $123.29 | +211.94% |
| December, 2030 | $121.38 | $115.70 | $123.00 | +217.08% |
0.47%
2.63%
Open in Yahoo
|
Open in Google
|
Open in Finviz
|
Open in MarketWatch
|
Open in EDGAR
|
Open in Reuters
Cap:
|
Volume (24h):